Evaluation of First-Line Coagulation Tests in Highly Active Antiretroviral Therapy (HAART) Naïve and Treated Group of HIV Infected Subjects

• Published in: Journal of Advances in Medical and Pharmaceutical Sciences Vol. 26; no. 3; pp. 1 - 8
• Main Authors: Martina, Ngwu Amauche, Lawrence, Ozoemena Chiadikobi, Elijah, Umeh Okechukwu, Basil, Ugwu Ifeanyichukwu, Innocent, Ozoume Chibuike
• Format: Journal Article
• Language: English
• Published: Science Domain International 25.01.2024
• Subjects: Life Sciences
• ISSN: 2394-1111; 2394-1111
• DOI: 10.9734/jamps/2024/v26i3672

Background: Coagulation disorders are common in patients with Human Immunodeficiency virus (HIV). Coagulation abnormalities occur as a result of HIV-related thrombocytopenia, induced hepatotoxicity due to highly active antiretroviral therapy (HAART) that impairs liver function and diminishes the fun...